Skip to main content
. 2018 Jan 5;103(4):679–687. doi: 10.3324/haematol.2017.182444

Figure 2.

Figure 2.

Progression-free survival and overall survival curves of patients with peripheral T-cell lymphoma not otherwise specified according to histone modifier gene mutations. (A) Progression-free survival and (B) overall survival curves of the training cohort. (C) Progression-free survival and (D) overall survival curves of the validation cohort.